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Introduction
Polarized cells use well-conserved mechanisms to sort pro-
teins into specific compartments (Mellman and Nelson, 2008), 
providing them with a directionality that is critically impor-
tant for both their function and meaningful integration into 
tissues. Central nervous system (CNS) neurons are prototypi-
cally polarized cells with specialized axonal and dendritic 
compartments that play essential roles in intercellular signal-
ing. Although neurons typically communicate by releasing 
low–molecular weight neurotransmitters accumulated in syn-
aptic vesicles, they also store and release peptides or small 
proteins such as brain-derived neurotrophic factor (BDNF), a 
member of the neurotrophin family. BDNF is known to regu-
late a wide variety of brain functions in humans, ranging from 
food intake (Gray et al., 2006) to memory retention (Egan 
et al., 2003). Indeed, a single amino acid replacement in 
pro-BDNF has been convincingly shown to correlate with a 
diminished capacity to remember words and sentences (Egan 
et al., 2003; Cathomas et al., 2010). Furthermore, in animal 
models of disease, reduced levels of BDNF have been associated 
with several conditions, including depression (Calabrese et al., 
2007), Rett syndrome (Chang et al., 2006), and Huntington’s 
disease (Zuccato et al., 2010).
Although many aspects of BDNF biology in the adult 
brain are thus beginning to be well appreciated, the subcellular 
localization of this secreted protein in neurons of the adult CNS 
is still very unclear, in large part because of the very low levels 
of endogenous BDNF. To address this question, several studies 
have resorted to neuronal cultures prepared from the embryonic 
Although brain-derived neurotrophic factor (BDNF) regulates numerous and complex biological pro-cesses including memory retention, its extremely 
low levels in the mature central nervous system have 
greatly complicated attempts to reliably localize it. Using 
rigorous specificity controls, we found that antibodies re-
acting either with BDNF or its pro-peptide both stained 
large dense core vesicles in excitatory presynaptic ter-
minals of the adult mouse hippocampus. Both moieties 
were 10-fold more abundant than pro-BDNF. The lack 
of postsynaptic localization was confirmed in Bassoon 
mutants, a seizure-prone mouse line exhibiting markedly 
elevated levels of BDNF. These findings challenge previ-
ous conclusions based on work with cultured neurons, 
which suggested activity-dependent dendritic synthesis 
and release of BDNF. They instead provide an ultrastruc-
tural basis for an anterograde mode of action of BDNF, 
contrasting with the long-established retrograde model 
derived from experiments with nerve growth factor in the 
peripheral nervous system.
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(Rauskolb et al., 2010), and (3) a mutant line displaying sei-
zure episodes that are accompanied by markedly elevated 
levels of BDNF (Heyden et al., 2011). Antibodies against the 
BDNF prodomain were also used as an independent means of 
localizing BDNF as well as to generate information about 
the status of its cleaved prodomain (described hereon as the 
pro-peptide).
Results
Antibodies to BDNF and pro-BDNF reveal 
similar staining patterns
Hippocampal sections prepared from 8-wk-old animals were 
incubated either with the monoclonal BDNF antibody Mab#9 
(anti-BDNF; Fig. 1 B) or with polyclonal antibodies recogniz-
ing the BDNF prodomain (anti–pro-BDNF; Fig. 1 H). Tissues 
from age-matched mice engineered to delete BDNF from neu-
rons (cbdnf ko; Rauskolb et al., 2010) were used as a negative 
CON (Fig. 1, C, D, I, and J). In addition, sections from a knockin 
mouse line expressing Bdnf-Myc (Fig. 1 E; Matsumoto et al., 
2008) were incubated with Myc antibodies (anti-Myc), with 
wild-type (WT) tissue used as a CON (Fig. 1, F and G). These 
three unrelated antibodies yielded strikingly similar staining pat-
terns (Fig. 1, B, E, and H). In particular, BDNF-, pro-BDNF–, 
and Myc-immunoreactivity (IR) were each most prominently dis-
tributed in the cell bodies and axon terminals of the mossy fiber 
projection pathway, whereas the layers comprising the CA1 area 
were only weakly stained, especially in the septal hippocampus.
rodent hippocampus (Goodman et al., 1996; Hartmann et al., 
2001; Kojima et al., 2001; Egan et al., 2003; Adachi et al., 2005; 
Dean et al., 2009; Matsuda et al., 2009; Jakawich et al., 2010). 
In most cases, conclusions about the localization of BDNF 
were inferred from visualization experiments using transfected 
tagged BDNF constructs, with recent studies concluding that 
BDNF is transported in and released from both axons and den-
drites (Adachi et al., 2005; Dean et al., 2009; Matsuda et al., 
2009; Jakawich et al., 2010). As firmly established by in situ 
hybridization studies, the Bdnf gene is expressed in an activity-
dependent fashion by numerous excitatory neurons (Zafra et al., 
1990), with protein levels increasing by 10-fold during the 
first 3 wk after birth, in parallel with the development of syn-
aptic activity (Tao et al., 1998; Kolbeck et al., 1999). Nonethe-
less, BDNF remains, even in the adult brain, an extremely rare 
protein, making its unambiguous detection in vivo a challenging 
task that is further complicated by the early death of Bdnf-null 
mutant animals, thus precluding their use as age-matched con-
trols (CONs; Ernfors et al., 1994; Jones et al., 1994).
Given that an understanding of the mode of action of se-
creted proteins depends on a detailed knowledge of their subcellu-
lar localization, the present study investigates the distribution 
of BDNF in the adult hippocampus at both light microscopic 
and ultrastructural levels using three lines of transgenic ani-
mals: (1) a BDNF knockin line allowing the use of antibodies 
directed against a tagged version of the BDNF gene (Matsumoto 
et al., 2008), (2) a line conditionally lacking BDNF in adult 
neurons allowing for the specificity control of BDNF antibodies 
Figure 1. -BDNF, -Myc, and –pro-BDNF antibodies all 
generate similar staining patterns. (A) A schematic represen-
tation of the BDNF precursor pro-BDNF and the two cleavage 
products pro-peptide and BDNF. (B) Low-power view of a 
WT hippocampal section stained with anti-BDNF antibodies. 
Note the intense staining in the hilus of the DG and in SL of 
CA3, each of which contains the axon terminals of mossy 
fibers. (C and D) Higher magnification view of the DG (C) 
and CA3 region (D) of the cbdnf ko hippocampus stained 
with anti-BDNF. Note the absence of immunoreactive signals 
in all cellular and neuropil layers. GCL, granule cell layer; H, 
hilus; IML, inner molecular layer; PCL, pyramidal cell layer. 
(E) Bdnf-Myc hippocampi stained with Myc antibodies show a 
similar staining pattern to that produced by BDNF antibodies. 
(F and G) Note the absence of staining in the corresponding 
DG (F) and CA3 regions (G) of WT sections treated with Myc 
antibodies. (H) Polyclonal pro-BDNF antibodies yield a simi-
lar pattern to that of anti-BDNF. (I and J) The same antibodies 
do not produce an immunoreactive signal in hippocampal 
sections from cbdnf ko animals. (B, E, and H) Arrows denote 
the end bulb of the mossy fiber projection, which delineates 
CA3 and CA1. Note the relative lack of staining in CA1 in 
WT and Bdnf-Myc sections. Bars: (B, E, and H) 500 µm; 
(C, F, and I) 100 µm; (D, G, and J) 50 µm.
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CA3 neurons. Mossy fibers project through and terminate 
in stratum lucidum (SL) and are characterized by prominent 
specialized endings known as mossy fiber boutons (MFBs). 
Accordingly, strong BDNF-IR and pro-BDNF–IR were ob-
served within SL (Figs. 1 [B, E, and H] and 2 [D–F]). Using 
high-resolution confocal microscopy, both BDNF-IR and pro-
BDNF–IR were found to be colocalized to the same subset of 
MFBs (Fig. 3, A–C).
Additional markers were then applied to identify the type 
of vesicles containing BDNF-IR and to compare the distribu-
tion of BDNF with other peptides known to be anterogradely 
transported by granule cells. As expected, BDNF-IR did not 
colocalize with the synaptic vesicle markers synaptophysin 
(SYP; Fig. 3, D and E) or VGLUT-1 (Fig. 3, F and G). We then 
tested possible colocalization with Met-enkephalin (Met-enk), 
an opioid peptide also derived from a larger precursor protein 
and stored in dense core vesicles (DCVs; Cheng et al., 1995). In 
a small proportion of granule cells and their axons, Met-enk–IR 
was detected throughout the soma and initial dendritic segment 
(Fig. 3 I). Although Met-enk–positive granule cells invariably 
coexpressed BDNF-IR (Fig. 3 H), the immunoreactive signals 
of these two precursor-derived molecules remained separate, 
suggesting that they do not reside together in the same secretory 
vesicles (Fig. 3, J and K–M). Similar conclusions were reached 
with cholecystokinin (CCK), a neuropeptide transported along 
the mossy fiber projection pathway of the ventral mouse hippo-
campus (Gall et al., 1986). Double labeling with anti-CCK and -
BDNF revealed complete segregation of the two peptides within 
MFBs (Fig. 3, N–P).
BDNF-IR is detected in subsets of neurons
Low-power examination of BDNF-IR in the dentate gyrus (DG) 
revealed a subset of immunopositive granule cells in the supra- 
and infrapyramidal blades (Fig. 2 A). BDNF-IR varied in inten-
sity among the labeled cells, with staining concentrated in the 
somal apex (Fig. 2 A, inset). Anti–pro-BDNF staining was con-
fined to exactly the same subset of granule cells containing 
BDNF-IR (Fig. 2, B and C), with somal pro-BDNF–IR also con-
centrated at the apex (Fig. 2 B, inset). In addition, the hilar region, 
which contains mossy fiber collateral axons of the granule cells, 
was intensely stained (Fig. 2, A–C). In the CA3 region, a subset of 
pyramidal neurons also showed both BDNF-IR (Fig. 2, D and F) 
and pro-BDNF–IR (Fig. 2, E and F). High-resolution examina-
tion of sections labeled with anti-Myc and anti–pro-BDNF, along 
with antibodies against the Golgi matrix protein GM130, revealed 
Myc-IR throughout the soma and the initial dendritic segments 
(Fig. 2 G), whereas pro-BDNF–IR showed a similar, albeit more 
punctate, distribution (Fig. 2 H). Comparison with GM130-IR 
showed pro-BDNF–positive puncta closely associated with the 
Golgi apparatus (Fig. 2, I and J). In line with this, anti–pro-BDNF 
immunogold labeling localized the protein to the Golgi complex 
of CA3 somata (Fig. 2 K). In CA1, BDNF and pro-BDNF costain-
ing was also detected in a small number of pyramidal neurons in 
temporal hippocampus sections (unpublished data).
BDNF-IR and pro-BDNF–IR are both 
detected in presynaptic terminals
The granule cells give rise to mossy fiber axons, whose tar-
gets include the complex spines on proximal dendrites of 
Figure 2. Detection of BDNF-IR and pro-BDNF–IR in 
subsets of principal neurons. (A–C) Low-power confo-
cal stack of the DG. The same subset of granule cells 
(arrows) coexpresses BDNF-IR (A) and pro-BDNF–IR (B). 
Boxed areas are enlarged in the inset images show-
ing single BDNF-positive (A) and pro-BDNF–positive 
(B) granule cells counterstained with DAPI (blue), 
with labeling concentrated at the cell apex in distinct 
clusters (arrows) and partial overlap of BDNF and pro-
BDNF signals (C, inset). GCL, granule cell layer; H, 
hilus; IML, inner molecular layer. (C) The merged image 
reveals an overlap of both signals. (D–F) Confocal stack 
of area CA3, demonstrating BDNF-IR (D) and pro-
BDNF–IR (E) in a subset of pyramidal cell somata (ar-
rows). Nuclei are labeled with DAPI. The prominent 
band of IR in SL corresponds to the terminal portions of 
the mossy fiber projection. PCL, pyramidal cell layer. 
(F) Note the uniform overlap of red and green signals 
in the overlay image. (G–J) High-resolution confocal 
stack of a single CA3 neuron labeled with antibodies 
against Myc (G), pro-BDNF (H), and GM130 (I). Note 
that the Myc-IR (G) and pro-BDNF–IR (H) extending 
into the apical dendrite (arrowheads) closely corre-
spond to the Golgi complex (J, merged image). Ar-
rows mark initial dendritic segments originating from 
the cell body. (K) Electron micrograph showing the 
Golgi complex (delineated by arrows) of a CA3 neu-
ron labeled by anti–pro-BDNF immunogold. Clusters 
of gold grains aggregate around the cisterns of the 
Golgi apparatus. Bars: (A–F) 100 µm; (G–J) 10 µm; 
(K) 500 nm; (A–C, insets) 5 µm.
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synaptic vesicles, numerous synaptic contacts with CA3 com-
plex spines, nonsynaptic puncta adherentia at dendritic shafts, 
and a relatively large surface area. A subset of MFB profiles 
labeled with anti-BDNF (Fig. 4 A), anti-Myc (not depicted), 
or anti–pro-BDNF (Fig. 4 B) contained distinct aggregates of 
gold grains; at 10,000-fold magnification, these gold clusters 
were found to be associated with large vesicles encompassed 
by an electron-dense membrane. Although the vesicles were 
sometimes masked by gold grains, fortuitous grain distribution 
occasionally revealed an electron-dense core (Fig. 4, A and B, 
insets). Within MFB profiles of cbdnf ko sections, gold grains 
were never specifically associated with any type of organelle 
(Fig. 4, C and D). To assess the density of immunogold parti-
cles in MFB profiles, gold clusters and single gold grains were 
quantified in anti-BDNF and anti–pro-BDNF–labeled tissues 
Presynaptic BDNF labeling was also observed in the CA1 
region, whereby in stratum radiatum (SR), thin varicose processes 
labeled with anti-BDNF (Fig. 3, Q–S) and anti–pro-BDNF (not 
depicted) were sparsely distributed throughout the neuropil, 
likely corresponding to presynaptic Schaffer collateral axons 
originating from BDNF-positive CA3 neurons. Importantly, 
BDNF-IR did not colocalize with the postsynaptic marker 
synaptopodin (synpo; Fig. 3, R and S).
BDNF and pro-BDNF antibodies label 
secretory vesicles in presynaptic terminals
Ultrathin sections of SL were then examined at 2,000-fold 
magnification after immunogold labeling with BDNF and 
pro-BDNF antibodies. MFBs were identified based on their 
typical morphological characteristics, namely a high density of 
Figure 3. Presynaptic localization of BDNF-
IR. (A–C) High-resolution optical slice of SL 
showing Myc-IR (A) and pro-BDNF–IR (B) in 
the same subset of MFBs (arrows). (C) Note 
the significant colocalization of red and green 
puncta in the overlay. (D and F) Merged im-
ages of SL labeled with antibodies to Myc and 
SYP (D) or Myc and VGLUT-1 (F). (E and G) 
Although BDNF-positive puncta are closely 
associated with SYP- and VGLUT-1–positive 
puncta, closer inspection at high magnification 
reveals segregation of the two markers (ar-
rows), confirming that BDNF is presynaptically 
expressed but not in synaptic vesicles. (H–M) 
Costaining with antibodies against Myc and 
Met-enk. In the small subset of granule cells 
that coexpresses Myc-IR (H) and Met-enk–IR (I), 
puncta are similarly distributed throughout the 
cell but show little overlap (J). Asterisks mark 
the positions of the nucleus. Similarly, a small 
proportion of MFBs (arrows) in SL coexpresses 
Myc-IR (K) and Met-enk–IR (L); however, in 
the merged image (M), Myc- and Met-enk–IR 
puncta do not overlap. (N–P) High-resolution 
optical slice of SL demonstrating expression of 
Myc-IR (N) and CCK-IR (O) in mossy fiber termi-
nals. Single asterisks label the CCK-IR profile, 
and double asterisks label the Myc-IR profile. 
(P) The merged image indicates complete seg-
regation of the two peptides in the mossy 
fiber projection. (Q) High-resolution confocal 
image of SR in the CA1 region of a BDNF-
Myc mouse. Labeling with anti-Myc antibod-
ies reveals localization of BDNF in fine axonal 
processes (thin arrows in Q–S). (R) Colabeling 
with antibodies against synpo reveal the rela-
tive location of dendritic spines. (S) An overlay 
of anti-Myc and anti-synpo–labeled section 
shows presynaptic localization of BDNF, with 
close apposition between BDNF-IR and synpo-
positive spines (white circles and filled arrows 
in Q–S). Bars: (A–C, E, G, and K–S) 5 µm; (D) 
30 µm; (F) 50 µm; (H–J) 10 µm.
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comparable between WT/Bdnf-Myc mice (4.69 ± 1.09 
grains/µm2) and cbdnf ko mice (4.08 ± 2.02 grains/µm2; 
P = 0.31; Fig. 6 M).
Localization of BDNF-IR and pro-BDNF–IR 
in Bsn mutants
Next, we examined the hippocampus of mice lacking the pre-
synaptic protein Bassoon, as these mutants develop episodic 
generalized seizures (Altrock et al., 2003) and have enlarged 
cortices and hippocampi (Angenstein et al., 2007). Concurrent 
with the development of seizures, BDNF protein levels become 
significantly higher than those measured in adult CON litter-
mates (see Fig. 10 C; Heyden et al., 2011). Whereas Bassoon 
(Bsn) mutants showed the typical distribution pattern of BDNF-IR 
and pro-BDNF–IR, a dramatic increase in staining intensity 
largely confined to the neuropil was observed (compare CON in 
Fig. 7 [A–D] with Bsn in Fig. 7 [E–H]). In contrast, granule cell 
and compared between sections from pooled WT/Bdnf-Myc 
mice and cbdnf ko mice. Anti-BDNF–labeled MFB profiles 
showed a mean density of 2.67 ± 0.35 clusters/µm2 in WT/
Bdnf-Myc animals compared with 0.38 ± 0.12 clusters/µm2  
(P < 0.005) in cbdnf ko profiles (Fig. 4 E). Moreover, single 
gold grain densities were significantly reduced in cbdnf ko 
MFB profiles, with 5.63 ± 0.94 grains/µm2 compared with 
21.99 ± 2.57 grains/µm2 in WT/Bdnf-Myc (P < 0.005; Fig. 4 F). 
Similarly, pro-BDNF immunogold labeling showed a mean 
density of 2.01 ± 0.43 clusters/µm2 and 27.44 ± 8.21 single 
grains/µm2 in MFB profiles from WT/Bdnf-Myc animals, 
whereas in comparison, MFB profiles from cbdnf ko animals 
showed significant reductions in cluster (0.14 ± 0.10/µm2; 
P < 0.05; Fig. 4 E) and single grain (5.82 ± 2.06/µm2; P < 0.05; 
Fig. 4 F) densities, respectively.
Although BDNF immunogold labeling was mostly con-
centrated in presynaptic terminals, labeled vesicles were also 
occasionally observed within unmyelinated axon segments in 
SL (Fig. 5 A), which in fortuitous sections could be seen to give 
rise to giant MFBs (Fig. 5 B).
Ultrathin sections of SR (CA1) labeled with anti-BDNF 
and anti–pro-BDNF immunogold were also examined, and, as 
expected, large cluster-labeled secretory vesicles were observed 
within small axon terminals (Fig. 5 C). Depending on the proxi-
mal distal level of SR, these infrequent labeled boutons likely 
correspond to Schaffer collateral terminals or entorhinal termi-
nals. No such labeled terminals were observed in cbdnf ko sec-
tions (Fig. 5 D).
BDNF-IR and pro–BDNF-IR are not 
detected in dendrites
Next, we examined the possible localization of BDNF in den-
drites by analyzing sections double labeled with anti-Myc 
and anti–microtubule-associated protein–2 (MAP-2). Both in 
BDNF-positive granule cells and CA3 neurons, Myc-IR only 
extended as far as the initial dendritic segments, and there was 
no evidence of colocalization in SL (Fig. 6, A–C). Sections 
were alternatively labeled with antibodies to Arc/Arg3.1, an 
immediate early gene product up-regulated in somata and 
dendrites during elevated synaptic activity (Lyford et al., 1995). 
Confocal scanning revealed that the majority of granule cells 
labeled with BDNF-IR and pro-BDNF–IR also expressed Arc/
Arg3.1-IR (Fig. 6, D–G). Although Arc/Arg3.1-IR was seen 
throughout the soma and dendritic arbor, strong coexpression of 
BDNF-IR and pro-BDNF–IR was confined to the cell soma 
(Fig. 6, D–G).
In ultrathin sections prelabeled either with anti-BDNF 
or anti–pro-BDNF immunogold, gold grains were sparsely 
distributed within dendritic profiles (Fig. 6, H and K). When 
profiles were thoroughly scrutinized for specifically labeled 
vesicles or endosomes, none was found to be stained above 
the background levels observed in dendrites from cbdnf ko 
sections (Fig. 6, I and L). Gold grain quantification of 
anti-BDNF–labeled sections (Fig. 6 J) revealed a mean den-
sity of 3.56 ± 0.45 grains/µm2 in WT/Bdnf-Myc mice versus 
4.72 ± 0.91 grains/µm2 in cbdnf ko mice (P = 0.81). Similarly, 
in anti–pro-BDNF–stained sections, mean densities were 
Figure 4. Ultrastructural localization of BDNF and pro-BDNF immunogold 
labeling in MFBs. (A) Electron micrograph of an ultrathin section of WT SL 
prelabeled with anti-BDNF immunogold. Numerous gold clusters (arrows) 
are associated with large secretory vesicles within the bouton (see inset). 
sp, dendritic spine. (B–D) An anti–pro-BDNF–labeled WT MFB containing 
cluster-labeled secretory vesicles (arrows). The inset image exemplifies a 
labeled large DCV. Large secretory vesicles labeled with gold clusters were 
not found in anti-BDNF–labeled (C) or anti–pro-BDNF–labeled (D) MFBs 
from cbdnf ko mice, confirming the specificity of the signal in WT sections. 
(E and F) Quantification of BDNF and pro-BDNF immunogold labeling in 
WT versus cbdnf ko MFBs. MFBs from WT and BDNF-Myc mice (n = 5 for 
anti-BDNF and n = 4 for anti–pro-BDNF) have a significantly higher density 
of gold clusters (E) and single gold grains (F) than MFBs from cbdnf ko mice 
(n = 3). *, P < 0.05; **, P < 0.005. Error bars represent SEM. Bars: (A–D) 
500 nm; (A and B, insets) 50 nm.
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Fig. 8 E) and grains (17.2 ± 2.8 grains/µm2; Fig. 8 F) compared 
with CON profiles (0.96 ± 0.04 clusters/µm2 with P < 0.005 and 
10.1 ± 0.9 grains/µm2 with P < 0.05, respectively); these rela-
tively low increases in mean cluster densities are a result of the 
larger areas of MFB profiles in Bsn mutants.
Gold grain distribution and density in dendrites were also 
compared between Bsn mutant (Fig. 9, C and D) and CON tis-
sues (Fig. 9, A and B). Dendritic profiles were again scrutinized 
for evidence of labeled vesicles, but none was found in tissues 
from either group. Density measurements revealed background 
values in Bsn mutant mice similar to those observed in CON 
mice, both in tissues labeled with anti-BDNF (5.4 ± 0.4 grains/µm2 
for Bsn mutant vs. 5.7 ± 0.5 grains/µm2 for CON; P = 0.66; 
Fig. 9 E, left) and anti–pro-BDNF (5.1 ± 0.1 grains/µm2 for Bsn 
mutant vs. 6.3 ± 0.3 grains/µm2 for CON; P = 0.12; Fig. 9 E, 
right). Increased labeling density was not detected in the extra-
cellular space or in nonneuronal cell types such as astrocytes.
Verification of background  
immunogold labeling
To determine whether background gold labeling is evenly dis-
tributed over different subcellular compartments, we extended 
the quantitative gold grain analysis to dendritic spine profiles 
and myelinated axon profiles in SL, as they are devoid of cluster-
labeled organelles. Quantification of single gold grains over-
lying these profiles revealed that the density of background 
gold labeling depends on the type of subcellular compartment 
(Table 1). The mean values for gold grain densities in spine and 
myelinated axon profiles did not differ between WT/Myc ver-
sus cbdnf ko or WT versus Bsn mutant tissues. Therefore, spines 
and myelinated axons from WT mice do not exhibit anti-BDNF 
and anti–pro-BDNF immunogold labeling above the back-
ground levels observed in cbdnf ko tissues, nor do they contain 
specifically labeled organelles.
Biochemical detection and quantification  
of the BDNF pro-peptide
The identity of the molecules recognized by the BDNF anti-
bodies in the immunochemistry experiments was then determined 
bodies from Bsn mutants did not show increases in anti-BDNF 
(Fig. 7 I) or anti–pro-BDNF (Fig. 7 J) staining intensities, 
although a much higher proportion of cells was labeled in 
comparison with CON tissues. Granule cell dendrites in the 
molecular layer remained unlabeled in Bsn mutants, whereas in 
the CA3 region, the stark increase in BDNF-IR (Fig. 7 G) and 
pro-BDNF–IR (Fig. 7 H) was confined to SL. Closer examina-
tion revealed intense presynaptic labeling in MFB profiles 
(Fig. 7, K and L), which was confirmed by a lack of colocaliza-
tion with the postsynaptic markers synpo (Fig. 7 K) and MAP-2 
(Fig. 7 L), respectively.
Enhanced BDNF staining in Bsn mutants was not only 
confined to the granule cell–CA3 projection pathway. In the 
CA1 region, where BDNF-IR can usually only be detected at 
high magnification (compare Fig. 1 with Figs. 3 Q and 5 D), a 
conspicuous band of punctate BDNF-IR and pro-BDNF–IR 
was observed at the border of SR and stratum lacunosum–
moleculare (SL-M; Fig. S1, A–C), corresponding to a region 
known to harbor fibers from the entorhinal cortex (Amaral and 
Lavanex, 2006). Importantly, these increased signals colocal-
ized (Fig. S1 D), showing no overlap with either synpo-IR 
(Fig. S1 E) or glial fibrillary acidic protein (GFAP)–IR (Fig. S1 F), 
which label dendritic spines and reactive astrocytes, respec-
tively. This suggests that entorhinal neurons also represent a 
possible presynaptic source of BDNF for CA1 neurons.
Immunogold-labeled sections from both WT and Bsn  
mutants were then examined at 2,000-fold magnification. In com-
parison with CON animals (Fig. 8, A and B), a higher number 
of labeled MFB profiles containing more BDNF-positive DCVs 
was observed in sections from Bsn mutants (Fig. 8, C and D), 
with clusters accumulated at the synaptic membrane. This was 
confirmed by quantification, with anti-BDNF–labeled MFBs 
containing a significantly higher density of gold clusters (1.7 ± 0.3 
clusters/µm2; Fig. 8 E) and grains (14.4 ± 2.5 grains/µm2; Fig. 8 F) 
compared with CONs (0.8 ± 0.01 clusters/µm2 with P < 0.05 
and 6.9 ± 0.5 grains/µm2 with P < 0.05, respectively). Similarly, 
anti–pro-BDNF–labeled profiles from Bsn mutants also displayed 
a higher density of gold clusters (2.02 ± 0.27 clusters/µm2; 
Figure 5. BDNF and pro-BDNF immunogold labeling 
in preterminal axons. (A) In sections treated with anti-
BDNF antibodies, labeled vesicles (arrows and inset) 
were observed in unmyelinated mossy fiber axons. (B) An 
electron micrograph showing a mossy fiber terminating 
into a bouton (dashed outline). The arrow points to an 
anti–pro-BDNF–labeled vesicle (see inset), which is likely 
en route to the terminal. ax, axon; sp, dendritic spine. 
(C) Anti-BDNF labeling of a presynaptic terminal in SR in 
CA1. Large silver-enhanced gold clusters (arrows) were 
observed. at, axon terminal. (D) Anti-BDNF staining of 
sections from cbdnf ko yielded nonspecific background 
labeling. Bars: (A–D) 500 nm; (A and B, insets) 100 nm.
 o
n
 M
arch 12, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published March 12, 2012
781Presynaptic localization of BDNF • Dieni et al.
and incubation conditions used, no measurable proteolysis of 
recombinant pro-BDNF (500 pg) added to the lysates at the be-
ginning of the extraction procedure could be detected (Fig. S2). 
The recovery of added recombinant pro-BDNF was 102.2 ± 
5.8% (n = 4).
Discussion
Our study reveals that in the adult hippocampus, BDNF and its 
cleaved pro-peptide are stored in large DCVs located in the 
presynaptic terminals of excitatory neurons. Both in WT and 
Bsn mutant mice, BDNF and its pro-peptide are stored at 
roughly equimolar ratios and are 10-fold more abundant than 
pro-BDNF in hippocampal lysates. Together with the lack of 
any detectable BDNF staining in dendrites or spines, our re-
sults provide direct support for an anterograde mode of action 
for BDNF in the intact CNS. They also offer a morphological 
substrate for recent findings indicating that the release of en-
dogenous BDNF accounts for some of the rapid calcium tran-
sients observed at synaptic sites on dendrites of CA3 neurons 
(Lang et al., 2007).
using hippocampal lysates from WT and mutant mice (cbdnf 
ko and Bsn). Immunoprecipitates were analyzed by Western 
blotting (WB) and probed with either the BDNF polyclonal 
antibody N-20 or the monoclonal antibody 5H8, which rec-
ognizes an epitope in the prodomain of BDNF (Fig. 1 A). 
These experiments revealed the presence not only of pro- 
BDNF (32 kD) but also of the much more abundant pro- 
peptide (17 kD; Fig. 10 A; also see Fig. 1 A). Both signals 
were absent in lysates from cbdnf ko animals (Fig. 10 A). Quan-
tification of the corresponding signal intensities revealed that 
the ratio of pro-peptide versus pro-BDNF is 10.3 ± 2.0 (n = 3; 
Fig. 10 B), similar to that of BDNF versus pro-BDNF (11 ± 
2.0; n = 3; Fig. 10, B and C). A similar analysis of hippocam-
pal lysates from Bsn mutants confirmed an approximate three-
fold increase each in BDNF, its pro-peptide, and pro-BDNF 
in mutant tissues (Fig. 10 C). These results also indicate that 
the respective ratios of BDNF and the pro-peptide versus pro-
BDNF are similar to what is observed in WT animals. Of note 
is that the consistent detection of BDNF pro-peptide was only 
possible after glutaraldehyde fixation of the transfer membrane 
(see Materials and methods). Furthermore, under the lysate 
Figure 6. BDNF-IR does not extend beyond proxi-
mal dendrites. (A) Myc-IR in the CA3 region show-
ing immunoreactive neuronal somata (asterisks) in 
the pyramidal cell layer (PCL) and Myc-positive MFB 
profiles in SL. (B) Anti–MAP-2 staining showing the 
distribution of pyramidal cell dendrites in CA3. 
(C) The merged image confirms that Myc-IR is prefer-
entially confined to cell bodies in the pyramidal cell 
layer and presynaptic terminals in SL. (A–C) Arrows 
denote limited Myc-IR in proximal apical dendrites. 
(D–F) High-resolution confocal stack of the DG la-
beled with antibodies against BDNF (D), pro-BDNF 
(E), and Arc/Arg3.1 (F). The filled arrows label Arc/
Arg3.1-positive, BDNF-negative cells, and the open 
arrows show BDNF-positive, Arc/Arg3.1-negative 
cells. GCL, granule cell layer; H, hilus; IML, inner 
molecular layer. (G) The merged image demon-
strates that the majority of granule cells expressing 
BDNF-IR and pro-BDNF–IR also show Arc/Arg3.1-IR. 
(H–M) Nonspecific BDNF and pro-BDNF immuno-
gold labeling in dendrites (den). In WT sections 
labeled with BDNF (H) or pro-BDNF (K) antibodies, 
gold grains are distributed throughout the dendrites 
but do not label any specific organelles. In cbdnf ko 
sections labeled with the same antibodies, a similar 
gold grain distribution to WT dendrites is observed 
for both BDNF (I) and pro-BDNF (L) antibodies. 
Quantification of gold grain density in dendrites re-
veals no difference between pooled WT/Bdnf-Myc 
versus cbdnf ko tissues labeled with either BDNF (J) 
or pro-BDNF (M) antibodies. Error bars represent 
SEM. Bars: (A–G) 30 µm; (H, I, K, and L) 500 nm.
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to be involved in the regulated secretion of many other neuronal 
signaling peptides including Met-enk (Cheng et al., 1995), 
which was also used here as a presynaptic marker. DCVs are 
typically found in presynaptic terminals but rarely in postsynap-
tic structures such as dendrites or spines, with the notable ex-
ception of the DCVs containing the neuropeptides vasopressin 
and oxytocin, found in the dendrites of specialized neurosecre-
tory cells (Kennedy and Ehlers, 2011).
Using cultured cells to study the cell 
biology of BDNF
Numerous previous studies have used cultured hippocampal 
neurons to study the storage and release of BDNF (Haubensak 
et al., 1998; Hartmann et al., 2001; Wu et al., 2004; Adachi 
et al., 2005; Brigadski et al., 2005; An et al., 2008; Dean et al., 
2009; Matsuda et al., 2009). They all come to the conclusion that 
BDNF is stored in and released from both axonal and dendritic 
compartments, raising the question of what could underlie the 
apparent discrepancy with our findings. Although the majority 
of these studies utilize neurons transfected with a cDNA encod-
ing a fluorescently tagged form of BDNF, some of the conclu-
sions are also based on the detection of endogenous BDNF 
in vitro. However, cultured embryonic neurons grow in a very 
different environment compared with neurons in vivo, with 
fewer and less intimate cell–cell interactions between neigh-
boring neurons and astrocytes, an incomplete ECM, and a lack 
of laminar input. In vivo, the development of neuronal circuits 
is spatially tightly regulated (Frotscher et al., 2000), whereas 
in vitro, synapses seem to form randomly. As a result of these 
cell-extrinsic differences, it is conceivable that cultured neurons 
fail to sort cargo-loaded vesicles as strictly as they do in vivo 
(Mellman and Nelson, 2008). In addition, we note that cultured 
neurons express significantly higher levels of BDNF than are 
detectable even in adult hippocampal extracts (unpublished data).
Immunohistochemical localization of BDNF 
in the CNS
The specificity of BDNF immunostaining in the adult brain is 
very difficult to ascertain, as Bdnf knockout animals die before 
reaching maturity, a fact that complicates the interpretation of 
previous immunohistochemical studies (Wetmore et al., 1991; 
Dugich-Djordjevic et al., 1995; Schmidt-Kastner et al., 1996; 
Altar et al., 1997; Conner et al., 1997; Yan et al., 1997; Luo 
et al., 2001; Danzer and McNamara, 2004; Tongiorgi et al., 
2004; Zhou et al., 2004; Agassandian et al., 2006; Avwenagha 
et al., 2006, Salio et al., 2007). Our study deals with the mature 
hippocampus, as much of the current interest in BDNF relates 
to its role in the adult brain, and the staining specificity of our 
BDNF monoclonal antibody was verified with tissues from age-
matched mice lacking BDNF in the CNS (Kolbeck et al., 1999; 
Rauskolb et al., 2010). The choice of BDNF antibody was also 
important, as none of the commercially available BDNF anti-
bodies we tested yielded specific staining (unpublished data). In 
addition, a mouse line was used in which Bdnf was replaced 
with a Myc-tagged version of the gene (Matsumoto et al., 2008), 
allowing additional control experiments to be performed with 
anti–human Myc antibodies on WT tissue sections. We note that 
a recent light microscopy study that also used a knockin strat-
egy to tag endogenous BDNF came to a conclusion very similar 
to our own, revealing identical labeling of the mossy fiber path-
way with antibodies directed against either the HA epitope used 
to tag BDNF or the BDNF prodomain (Yang et al., 2009). How-
ever, our biochemical results (see later part of Discussion) now 
indicate that pro-BDNF antibodies primarily detect the BDNF 
pro-peptide, which is present at much higher levels than uncleaved 
pro-BDNF. The pro-BDNF antibodies further validate our 
localization data, as they recognize an epitope unrelated to 
those detected by the antibodies to BDNF or Myc but similarly 
label presynaptic large DCVs. These organelles are well known 
Figure 7. Elevated BDNF staining in Bsn 
mutants. (A–D) Representative images from 
CON tissues showing anti-BDNF labeling in 
the DG (A) and CA3 area (C) and anti–pro-
BDNF–Mab5H8 labeling in the DG (B) and 
CA3 (D). GCL, granule cell layer; H, hilus; 
IML, inner molecular layer; PCL, pyramidal cell 
layer. Overall distribution and staining intensi-
ties highly resemble those described for WT 
and Bdnf-Myc animals in Fig. 2. (E–H) In the 
corresponding regions of Bsn mutant sections, 
BDNF- and pro-BDNF–Mab5H8-IR are mark-
edly increased in the hilus of the DG (E and F) 
as well as in SL (G and H). Note that lack of 
proportional increase in staining in the associ-
ated cell layers, namely the GCL (E and F) and 
pyramidal cell layer of CA3 (G and H). (I and 
J) High-power examination of the GCL reveals 
numerous albeit weakly labeled BDNF-positive 
(I) and pro-BDNF–Mab5H8-positive (J) granule 
cells, with labeling confined to the cell soma 
and no detectable dendritic staining in the inner 
molecular layer. (K and L) In SL of Bsn mutants, 
an increased density of labeled profiles was 
observed, with BDNF-IR (K) and pro-BDNF–IR-
Mab5H8 (L) showing virtually no overlap with 
the postsynaptic markers synpo (green; K) 
and MAP-2 (red; L), respectively. Bars: (A–H) 
100 µm; (I and J) 30 µm; (K and L) 15 µm.
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BDNF signaling have inferred the translation of BDNF mRNA 
in dendrites (Tanaka et al., 2008), it has not been possible thus 
far to assess directly whether dendritic BDNF mRNAs are 
translated locally. Thus, it is of particular significance that our 
experiments revealed a complete lack of specific BDNF pro-
tein signals in dendrites not only in WT but also in Bsn mutant 
animals. Although our experiments cannot rule out that func-
tionally relevant quantities of BDNF may be released from 
dendrites, they indicate that, at present, there is no structural 
basis for this speculation.
With regard to the biochemistry of BDNF, initial studies 
suggested that the most abundant, or indeed the only detectable, 
translation product in adult brain extracts was uncleaved pro-
BDNF (Chen et al., 2005; An et al., 2008). However, a signal of 
similar size and intensity to pro-BDNF can readily be detected 
in mice lacking BDNF in the CNS (Matsumoto et al., 2008). 
Furthermore, pulse-chase experiments showed that pro-BDNF 
is a short-lived intermediate that is rapidly processed intracellu-
larly (Matsumoto et al., 2008). BDNF, like all other neurotroph-
ins, is initially translated as a glycosylated precursor protein, 
presumably allowing the proper folding and disulfide bridging 
of the mature protein (Leibrock et al., 1989; Rattenholl et al., 
2001). Accordingly, we detected specific pro-BDNF–IR in the 
BDNF biosynthesis and processing
Although in situ hybridization experiments have long estab-
lished that BDNF mRNA can be unambiguously detected in the 
cell bodies of excitatory neurons (Hofer et al., 1990; Isackson 
et al., 1991), some studies have also suggested its presence in 
dendrites (Tongiorgi et al., 1997, 2004; An et al., 2008) and its 
active transport upon stimulation (Tongiorgi et al., 1997, 2004; 
Chiaruttini et al., 2009; Baj et al., 2011; Louhivuori et al., 2011; 
Wu et al., 2011). However, these experiments revealed that 
BDNF mRNA is predominantly detected in the most proximal 
part of the dendrite, whereas other actively transported mRNAs 
can be detected in dendrites hundreds of micrometers away 
from the soma, as is the case for the Arc/Arg3.1 (Lyford et al., 
1995), CaMKII- (Burgin et al., 1990; Miller et al., 2002), or 
dendrin (Link et al., 1995) mRNAs. This leaves the possibility 
that BDNF mRNA localizes to proximal dendrites by diffusion 
rather than active transport. Selective trafficking has also been 
difficult to assess, as activity-dependent transcription augments 
the intensity of the proximal mRNA signal, allowing more 
distal diffusion of the in situ hybridization enzymatic reaction 
product (Tongiorgi et al., 1997, 2004). Although elegant experi-
ments aimed at blocking protein synthesis and interfering with 
Figure 8. Higher density of BDNF-positive DCVs in MFBs of Bsn mutant 
animals. (A and B) Electron micrographs of MFBs from CON sections 
prelabeled with BDNF (A) or pro-BDNF (B) immunogold. Gold cluster– 
labeled secretory vesicles were occasionally observed in a subset of termi-
nals (arrows). sp, dendritic spine. (C and D) In MFBs from Bsn mutants, 
there was an increase in the number of cluster-labeled vesicles (arrows) as 
well as single gold grains, both in the case of BDNF (C) and pro-BDNF (D) 
immunogold. den, dendrite. (E and F) This was confirmed by quantifica-
tion. Error bars represent SEM. Bars, 500 nm.
Figure 9. BDNF is not targeted to dendrites in Bsn mutants. (A–E) Com-
parison of dendrites (den) in SL in CON (A and C) versus Bsn mutant tis-
sues (B and D) revealed a lack of difference in the density of gold grains, 
both in the case of BDNF immunogold (E, left) and pro-BDNF immunogold 
(E, right). Also note the general absence of DCVs within dendritic profiles 
of both CON and Bsn mutant animals. Error bars represent SEM. Bars, 
500 nm.
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for the Bsn mutation (Angenstein et al., 2007). Blocking ac-
tivity with carbamazepine in the Kv1.1 mutant prevents the 
development of megencephaly and restores BDNF mRNA to 
normal levels (Lavebratt et al., 2006). Despite the marked 
increase in BDNF and its pro-peptide in the Bsn mutant, both 
immunoreactive signals remained confined to presynaptic ter-
minals, with no detectable staining in either granule or pyra-
midal cell dendrites or glial cells (Bergami et al., 2008). In 
comparison with WT animals, the only remarkable change 
observed in the Bsn mutant was an increase in the density of 
BDNF-positive DCVs in MFBs. These observations are in 
line with earlier studies in the rat, in which chemically in-
duced seizure activity led to an increase in presynaptic BDNF 
staining (Vezzani et al., 1999; Scharfman et al., 2002; Danzer 
and McNamara, 2004). Despite the substantially higher BDNF 
levels, we did not detect any BDNF staining in the extracel-
lular space, suggesting that after its release, BDNF becomes 
rapidly diluted by diffusion as well as by cellular reuptake, 
thus preventing accumulation to a degree that would allow 
immunohistochemical detection.
BDNF and hippocampal mossy fibers
The hippocampal mossy fiber projection stands out as the 
most heavily stained structure in the adult CNS using either 
BDNF or pro-BDNF antibodies (Fig. 1). This pathway is thought 
to exhibit presynaptic long-term potentiation (LTP; Nicoll 
and Schmitz, 2005) and to be important for pattern com-
pletion as well as for the storage and recall of information 
Golgi apparatus of dentate granule cells and CA3 neurons but not 
in other organelles such as lysosomes or endosomes. Although 
the intracellular site of pro-BDNF cleavage and the participat-
ing proteases are yet to be identified, the existence of the BDNF 
pro-peptide in brain lysates has not been previously reported 
(see Fig. 10). This pro-peptide has hitherto escaped detection 
presumably because it is readily washed away from blotting 
membranes. This loss could be prevented by fixing the mem-
branes with glutaraldehyde after electrophoretic transfer (Karey 
and Sirbasku, 1989). Although we observed that prolonged 
stimulation of cultured neurons results in the cosecretion of 
BDNF and its pro-peptide (unpublished data), the biological 
significance of this corelease is unclear.
BDNF detection in the hippocampus  
of Bsn mutants
Mutant mice expressing a truncated version of the large pre-
synaptic protein Bassoon develop spontaneous epileptic sei-
zures for reasons that are only partially understood (Altrock 
et al., 2003). In line with the well-established link between 
excitatory neuronal activity and Bdnf transcription, BDNF 
protein levels were found to increase in parallel with, but not 
precede, the development of seizure episodes (Heyden et al., 
2011). It seems unlikely that Bassoon is directly involved in 
the increase in BDNF levels, as a mutation in the potassium 
channel Kv1.1 that also leads to seizure activity is accompa-
nied by a marked increase in BDNF mRNA and megenceph-
aly (Diez et al., 2003; Lavebratt et al., 2006), as is the case 
Table 1. Comparative gold grain densities in subcellular compartments devoid of cluster-labeled organelles
Anti-BDNF immunogold Anti–pro-BDNF immunogold
Subcellular profile WT/Myc cbdnf ko CON Bsn WT/Myc cbdnf ko CON Bsn
 n = 3 n = 3 n = 4 n = 4 n = 3 n = 3 n = 4 n = 4
Dendritea 3.6 ± 0.5 4.7 ± 0.9 6.9 ± 0.9 6.6 ± 0.7 4.7 ± 1.6 4.1 ± 1.5 6.3 ± 0.3 5.1 ± 0.1
Spine 19.3 ± 2.1 18.4 ± 3.8 15.0 ± 1.4 13.1 ± 0.9 18.2 ± 1.2 20.3 ± 4.5 13.8 ± 0.6 14.3 ± 1.6
Myelinated axon 9.6 ± 1.8 11.6 ± 0.7 8.3 ± 0.5 8.1 ± 1.2 12.2 ± 0.8 10.7 ± 0.7 8.5 ± 1.1 10.1 ± 1.5
Two-sided t tests for all profiles in both anti-BDNF immunogold and anti–pro-BDNF immunogold were P > 0.05. All values expressed as the group mean value ± SEM 
n value correspond to the number of animals examined per experiment. Subcellular profiles are represented as no. of grains/µm2.
aGold grain densities in dendrites are also presented in graph form in Fig. 6 (WT/Myc vs. cbdnf ko) and Fig. 9 (CON vs. Bsn mutant).
Figure 10. Biochemical detection of BDNF, its pro-
peptide, and pro-BDNF. IP of hippocampal lysates 
(500 µg) was performed either with an anti–pro-BDNF 
antiserum or with the BDNF antibody followed by WB 
with the antibodies indicated. (A) Both pro-BDNF and 
its pro-peptide were detected in WT (first lane) but 
not in cbdnf ko samples (second lane). Similar results 
were obtained using the pro-BDNF antibody AN-03 in 
IP and/or WB (not depicted). HIP, hippocampus; IB, 
immunoblot; non-glyc., nonglycosylated; rec., recom-
binant. (B) Note that the ratio of pro-peptide to pro-
BDNF is similar to that of BDNF and pro-BDNF (n = 3). 
Error bars represent the SEM of the three samples 
measured. (C) IP/WB analysis of hippocampal lysates 
from Bsn mutants reveals a relatively similar increase 
(approximately threefold) in the levels of BDNF and 
pro-BDNF (left, second lane) as well as pro-peptide 
and pro-BDNF (right, second lane) compared with 
CON tissues (left and right, first lanes). Recombinant 
BDNF pro-peptide and cleavage-resistant pro-BDNF 
were used as molecular mass markers.
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polyclonal antibody (anti–pro-BDNF; #ANT-006, batch AN-03; Alomone 
Labs) raised against the prodomain of BDNF protein (see Fig. 1 A). To deter-
mine whether the signals obtained with anti–pro-BDNF could also be ob-
served with other antibodies against the prodomain of BDNF, we tested a 
commercially available mouse monoclonal pro-BDNF antibody (anti–
pro-BDNF–Mab5H8; SC-65514; Santa Cruz Biotechnology, Inc.). The stain-
ing pattern produced by this antibody (as specified in the figure legends) 
was comparable with the results obtained with the polyclonal anti–pro-BDNF. 
Presynaptic components were detected with mouse monoclonal antibodies 
against the vesicular glutamate transporter 1 (anti–VGLUT-1; #135511; 
Synaptic Systems) and rabbit polyclonal antibodies against SYP (anti-SYP; 
Santa Cruz Biotechnology, Inc.); for postsynaptic labeling, mouse mono-
clonal antibodies against MAP-2 (anti-MAP-2; #M2320; Sigma-Aldrich), 
rabbit polyclonal antibodies against the spine apparatus protein synpo 
(anti-synpo; #S9567; Sigma-Aldrich), and guinea pig polyclonal antibodies 
against activity-related cytoskeletal protein (anti-Arc/Arg3.1; #156005; 
Synaptic Systems) were used. A mouse monoclonal antibody against the 
130-kD Golgi matrix protein (anti-GM130) was used for the detection of 
the Golgi complex (#610822; BD). For labeling of neuropeptides within 
the mossy fiber projection, rabbit polyclonal antibodies against Met-enk 
(anti–Met-enk; Millipore) and CCK (anti-CCK; #P06307; Millipore) were 
used. Astrocytes were detected with a guinea pig polyclonal antibody serum 
against GFAP (anti-GFAP; #031223; Advanced ImmunoChemical Inc.).
Immunofluorescence
As preliminary staining experiments with anti-Myc antibodies yielded high 
levels of nonspecific staining in sections from WT mice, the Myc antibody 
solution was preincubated with WT sections, and the solution was subse-
quently used to stain sections from Bdnf-Myc and WT mice. Except for this 
first blocking step, the staining protocol for all antibodies was identical, 
and TBS, pH 7.4, was used throughout to wash the sections. For staining 
with polyclonal antibodies, sections were blocked with 20% normal don-
key serum in TBS for 1 h; for staining with monoclonal antibodies, sections 
were blocked with 3% M.O.M (Mouse-on-Mouse blocking serum; Vector 
Laboratories) in TBS for 1 h. Primary antibodies were diluted in a solution 
of 3% BSA, 2% normal donkey serum, and 0.2% Triton X-100 in TBS to 
yield the following final concentrations/dilutions: 10 µg/ml anti-BDNF, 
0.4 µg/ml anti-Myc, 1.33 µg/ml anti–pro-BDNF, 3.3 µg/ml anti–VGLUT-1, 
4 µg/ml anti-SYP, 0.9 µg/ml anti-GM130, 2 µg/ml anti-Arc/Arg3.1, 
4 µg/ml anti–MAP-2, 1:2,000 anti-synpo, 3 µg/ml anti–Met-enk, 1:2,000 
anti-CCK, and 1:1,000 anti-GFAP. Sections were incubated for at least 
one night at 4°C in either one or more of these primary antibodies. For 
fluorescent signal detection, the following Alexa Fluor–conjugated sec-
ondary antibodies were used: donkey anti–rabbit-488 or -555, donkey 
anti–goat-555 or -488, donkey anti–mouse-555 or -647, and donkey 
anti–guinea pig–Cy5 (all purchased from Millipore). Labeled sections 
were mounted onto glass slides and coverslipped with fluorescent mount-
ing medium (Dako).
Confocal microscopy
Slide-mounted sections of immunolabeled hippocampi were viewed on an 
inverted microscope (Axiovert 200; Carl Zeiss) equipped with Plan Apo-
chromat 20× (0.75 NA) or 63× (oil differential interference contrast; 1.4 
NA) objectives and attached to a spectral confocal laser system (LSM 510; 
Carl Zeiss) powered by LSM 4.2 Meta software (Carl Zeiss). The tissue was 
scanned at room temperature with 488-, 543-, and 633-nm laser lines to 
detect the Alexa fluorophores 488, 555, and 647, respectively, and high-
resolution images of optical sections (z slices) were captured using sequen-
tial line (mean of four) scanning. Colocalization of two or three fluorophores 
was qualitatively assessed in the x, y, and z planes of each optical section. 
Maximal projection images of confocal z series (stacks) were generated 
where indicated in the figure legends. Minimal adjustments to image con-
trast and intensity were made in Photoshop CS (version 8.0.1; Adobe) 
using the levels or contrast/brightness functions. Images were arranged 
and annotated using CorelDRAW 12 software (Corel Corporation).
Immunogold EM
Immunogold prelabeling. 50-µm vibratome sections of perfusion-fixed hippo-
campi from WT, Bdnf-Myc, cbdnf ko, and Bsn mutant mice were thor-
oughly washed in 50 mM TBS, pH 7.4, and immersed for 2 h in a 
cryoprotecting solution (25% sucrose and 10% glycerol in 0.05 M PB) 
before being snap frozen in liquid nitrogen–cooled isopentane. After im-
mediate thawing and washing in 0.1 M PB, sections were incubated for 
1 h in blocking solution (3% M.O.M. in TBS for anti-BDNF staining and 
20% normal goat serum in TBS for anti–pro-BDNF and anti-Myc staining) 
(Bischofberger et al., 2006; Kerr and Jonas, 2008). Recent 
studies have also shown that long-term experience results in 
rearrangements of presynaptic MFBs (Galimberti et al., 2006, 
2010; Rekart et al., 2007) and that LTP induction results in a 
dramatic increase in MFB profile size accompanied by post-
synaptic spine growth and de novo formation of release sites 
(Zhao et al., 2012). Although it remains to be demonstrated 
that presynaptic release of BDNF is involved in these mor-
phological changes, endogenous BDNF signaling has been 
shown to account for some of the spontaneous, rapid calcium 
transients observed at synaptic sites on CA3 dendrites (Lang 
et al., 2007). In addition, -burst–induced release of endoge-
nous BDNF from mossy fibers is sufficient to induce intracel-
lular changes in postsynaptic CA3 neurons (Li et al., 2010). 
Furthermore, several previous studies in CA1 have pointed to 
the need for BDNF in order for LTP to reach maximal values 
(Korte et al., 1995; Patterson et al., 1996), and our results 
uncover a presynaptic location of BDNF in this hippocampal 
area (Figs. 5 and S1).
Conclusion
Our localization data provide a structural substrate for previous 
functional results, suggesting that BDNF exerts its action on 
postsynaptic CNS neurons primarily in an anterograde fashion 
(Altar et al., 1997; Zakharenko et al., 2003; Baquet et al., 2004). 
This mode of action is the converse of the long-established 
model based on NGF in the peripheral nervous system, whereby 
neurotrophins are released from various cell types, including 
smooth muscle cells, and then act retrogradely on presynaptic 
neurons. Together with the recent discovery that the NGF re-
ceptor TrkA causes neuronal death in the absence of its ligand, 
whereas the BDNF receptor TrkB does not (Nikoletopoulou et al., 
2010), these results suggest profound differences in the biology 
and directionality of growth factor signaling between the pe-
ripheral nervous system and the CNS.
Materials and methods
Mouse lines
Brains were obtained from the following lines of mice, all of which were 
used at 8 wk of age: WT (C57Bl6), Bdnf-Myc (Matsumoto et al., 2008), 
cbdnf ko (Rauskolb et al., 2010), and Bsn mutant (BsnEX4/5; Altrock 
et al., 2003). All experiments were performed in accordance with the institu-
tional guidelines of the University of Freiburg and the University of Basel.
Preparation of tissue for immunostaining
Mice (n = 7 for WT, n = 7 for Bdnf-Myc, n = 4 for cbdnf ko, and n = 7 for 
Bsn mutant) were transcardially perfused with 0.9% NaCl followed by a 
mixture of 4% PFA, 0.1% glutaraldehyde, and 0.3% picric acid in 0.1 M 
phosphate buffer (PB), pH 7.4. Brains were removed and postfixed with 
4% PFA in 0.1 M PB for 1 h before thorough washing in 0.1 M PB. Coro-
nal sections (50 µm) of the hippocampus were cut on a vibratome (Leica) 
and collected in 0.1 M PB. Sections along the septotemporal axis of the 
hippocampus were further processed either for immunofluorescent labeling 
or preembedding immunogold labeling.
Antibodies for immunostaining
BDNF was detected with the mouse monoclonal anti-BDNF antibody 
Mab#9 (anti-BDNF; Kolbeck et al., 1999) directed against the mature domain 
of BDNF (see Fig. 1 A). This antibody also recognizes the uncleaved form 
of BDNF, i.e., pro-BDNF (Fig. 1 A; Matsumoto et al., 2008). BDNF-Myc 
was detected with goat polyclonal c-Myc antibodies (anti-Myc; SC-789; 
Santa Cruz Biotechnology, Inc.). Pro-BDNF was detected with a rabbit 
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were produced in COS7 cells transfected with the corresponding cDNAs 
cloned in plasmid cytomegalovirus vectors. The concentrations of these 
proteins were then determined against known amounts of purified BDNF 
pro-peptide produced in Escherichia coli (Koshimizu et al., 2009). The 
COS7-derived cleavage-resistant pro-BDNF was used as a molecular mass 
marker, whereas WT pro-BDNF was used in recovery experiments with 
tissue lysates (Fig. S2)
Statistical analysis
All values are expressed as mean ± SEM. For BDNF and pro-BDNF immuno-
gold quantification, 10–20 MFBs and 30–40 dendrites per WT, Bdnf-Myc, 
cbdnf ko, and Bsn mutant mice were analyzed, and mean values for each 
animal were calculated. Group means (pooled WT/BDNF-Myc vs. cbdnf ko 
and WT vs. Bsn mutant) were compared using a two-sided Student’s t test. 
A probability of P < 0.05 was considered to be statistically significant.
Online supplemental material
Fig. S1 shows an increase in BDNF-IR and pro–BDNF-IR in area CA1 of 
the Bassoon mutant hippocampus. Fig. S2 shows the complete recovery 
of WT recombinant pro-BDNF from hippocampal lysates. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/ 
jcb.201201038/DC1.
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